Risk factors for cervical ipsilateral lymph node metastasis in papillary thyroid carcinoma

Author:

Yang Qiu-hui1,Ma Hai-guang2,Zhang Xiang-jian2,Zhang Xian-bo2

Affiliation:

1. Wenzhou Medical University

2. The Dingli Clinical College of Wenzhou Medical University

Abstract

Abstract Background: Papillary thyroid carcinoma (PTC)is the most common type of thyroid malignancy, characterized by slow progression, long survival, and low mortality rate. However, the cervical lymph node metastasis (CLNM) rate of PTC can reach up to 40%, and if the initial treatment is not appropriate, it is easy to relapse. Methods: We retrospectively analyzed the clinical data of 118 patients with PTC who underwent surgical treatment in our hospitals over the past decade. Furthermore, we analyzed whether the age, gender, tumor position, diameter, and other characteristics of patients were related to CLNM through univariate and multivariate analysis. At the same time, we also analyzed the factors related to skip metastasis in PTC. Results: The results of univariate analysis showed that CLMN was related to gender, tumor position, calcification, capsular infiltration, tumor diameter, tumor numbers, and lymph nodes of VI zone. Besides, the results of logistic regression analysis showed that CLMN was related to tumor position, calcification, tumor diameter, tumor numbers, and lymph nodes of VI zone. What’s more, we also found that upper polar thyroid tumors are more prone to jumping metastasis. Conclusion: The study of risk factors for CLNM in PTC will help identify patients who require selective lymph node dissection (SLND). Firstly, patients with primary tumor located in the upper pole of the thyroid gland need to carefully evaluate lymph node in the cervical region. Secondly, for PTC patients with negative preoperative evaluation of cervical lymph nodes, even if the VI area is judged negative during surgery, we still need to consider risk factors such as capsular infiltration, gender, and tumor position to comprehensively determine whether patients need SLND.

Publisher

Research Square Platform LLC

Reference23 articles.

1. Overview of the 2022 WHO Classification of Thyroid Neoplasms;Baloch ZW;Endocr Pathol,2022

2. Risk factors of cervical lymph node metastasis in multifocal papillary thyroid cancer;Zhang T;Front Oncol,2022

3. Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review;Cavalheiro BG;Cancers (Basel),2023

4. Prophylactic Central Neck Dissection for Clinically Node-Negative Papillary Thyroid Carcinoma;Alsubaie KM;Laryngoscope,2022

5. Igaue S, et al. Significance of Surgery for Resectable M1 Lymph Node Metastases Without Organ Metastasis in Esophageal Carcinoma in the Era of Neoadjuvant Treatment. Ann Surg Oncol; 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3